Paradigm Biopharmaceuticals Ltd (par) Logo

Paradigm Biopharmaceuticals Ltd (PAR)

___:___ · Healthcare
ASX Delayed
Cboe Live

What is live streaming pricing?

Stock prices will auto-update without reloading the page. How it works:

  • Flashing prices signify an increase (green) or decrease (red) from previous price. Otherwise, price is unchanged.
  • Expect a short delay while pricing data initially loads.
  • Note, prices only update during market hours (10am-4:13pm AEST).

More about Cboe Live pricing.

OK, got it
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE
Overview
Financials

PAR ASX Chart

Snapshot

Paradigm Biopharmaceuticals Ltd. (PAR) is a late-stage drug development company driven by a purpose to improve patients' health and quality of life by discovering, developing, and delivering pharmaceutical therapies.

Share Price Activity (ASX)

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2024 YTD
1 Year
vs Sector (1yr) -64.78%
vs ASX 200 (1yr) -75.60%

Size

Market Cap Question Mark Icon
Excludes mandatory escrowed shares and foreign shares.
ASX Rank 936 of 2,382
Sector Rank 69 of 226

Key Fundamentals

Shares Issued
Sector Healthcare
Similar Companies NXS / QTM / BD1
EPS -$0.233
DPS $0.00
Book Value Per Share $0.145

Broker Consensus

PAR is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Latest Paradigm Biopharmaceuticals Ltd News

More News

Announcements

Price Sensitive only

Corporate Overview

Corporate Details

Head Office Melbourne VIC 3000
Website www.paradigmbiopharma.com
Registry Automic Group
Auditor RSM Australia Partners
Date Listed 19 Aug 2015

Upcoming Calendar (Forecasted)

Date Event
23/08/2024 Report (Prelim)
23/08/2024 Report (Annual)
26/02/2025 Report (Interim)

Former Company Names

  • Paradigm Biopharmaceuticals Ltd has no former company names.

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors

Management

Director Transactions

PAR directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
29/02/24 Donna Skerrett Issued 1,000,000 $0.350 $350,000 As advised by the company
29/02/24 Paul Rennie Issued 1,200,000 $0.350 $420,000 As advised by the company
30/11/23 Helen Fisher Issued 1,021 $0.429 $438 Rights issue
30/11/23 Helen Fisher Issued 766 $0.389 $298 Rights issue
30/11/23 Paul Rennie Issued 349,500 $0.390 $136,305 Rights issue
30/11/23 Paul Rennie Sell +300,000 $0.390 ($117,000) As advised by the company
30/11/23 Paul Rennie Issued 466,000 $0.430 $200,380 Rights issue
18/05/23 Helen Fisher Buy +10,204 $0.982 $10,020 On-market trade
12/05/23 Paul Rennie Buy +73,851 $1.03 $76,001 On-market trade
19/12/22 Paul Rennie Buy +47,720 $1.29 $61,521 On-market trade
14/09/22 Paul Rennie Issued 133,435 $1.30 $173,466 Rights issue
14/09/22 Paul Rennie Issued 100,410 $1.30 $130,533 Rights issue
08/03/22 Paul Rennie Buy +48,167 $1.05 $50,634 On-market trade
25/01/22 Donna Skerrett Buy +375,000 $1.89 $708,750 As advised by the company
19/11/20 Donna Skerrett Buy +500,000 $3.05 $1,525,000 As advised by the company
19/11/20 Paul Rennie Buy +600,000 $3.05 $1,830,000 As advised by the company
19/11/20 Christopher Fullerton Transfer 1,000,000 $3.05 $3,050,000 Off-market transfer
19/11/20 Christopher Fullerton Transfer 1,000,000 $3.05 $3,050,000 Off-market transfer
11/05/20 John Gaffney Sell +115,695 $2.37 ($274,118) On and off market trades
08/05/20 Paul Rennie Sell +4,131,568 $2.30 ($9,502,606) Off-market trade
08/05/20 Graeme Kaufman Sell +184,216 $2.30 ($423,697) Off-market trade
13/03/20 Paul Rennie Buy +28,500 $1.75 $49,786 On-market trade
13/03/20 Paul Rennie Buy +28,500 $1.75 $49,786 On-market trade
13/11/19 Christopher Fullerton Transfer 15,000 $2.99 $44,850 Off-market transfer
13/11/19 Christopher Fullerton Transfer 15,000 $2.99 $44,850 Off-market transfer
13/11/19 Christopher Fullerton Buy +100,000 $3.01 $301,045 On-market trade
07/11/19 Paul Rennie Buy +197,355 $2.93 $578,250 Employee Share Ownership Plan
28/06/19 Paul Rennie Buy +35,000 $1.40 $49,000 On-market trade
27/06/19 Christopher Fullerton Buy +10,000 $1.48 $14,840 On-market trade
13/05/19 Christopher Fullerton Issued 100,000 $1.48 $148,402 Rights issue
13/05/19 Christopher Fullerton Issued 4,500 $1.48 $6,678 Rights issue
23/04/19 Christopher Fullerton Buy +15,000 $1.65 $24,715 On-market trade
23/04/19 Christopher Fullerton Buy +4,500 $1.65 $7,415 On-market trade
04/03/19 Christopher Fullerton Buy +100,000 $1.18 $118,116 On-market trade
13/12/18 Paul Rennie Buy +780,392 $0.698 $545,000 Employee Share Ownership Plan
04/05/18 Christopher Fullerton Buy +36,000 $0.425 $15,300 On-market trade
13/11/17 Paul Rennie Buy +210,000 $0.629 $132,090 Employee Share Ownership Plan
23/06/17 Paul Rennie Buy +285,000 $0.353 $100,619 On-market trade
08/12/16 Christopher Fullerton Buy +82,855 $0.462 $38,307 As advised by the company
08/12/16 Christopher Fullerton Transfer 617,145 $0.440 $271,544 Off-market transfer
08/12/16 Christopher Fullerton Buy +82,855 $0.462 $38,307 As advised by the company
08/12/16 John Gaffney Buy +31,250 $0.480 $15,000 Participation in share purchase plan
08/12/16 Paul Rennie Buy +556,667 $0.443 $246,368 Employee Share Ownership Plan
08/12/16 Graeme Kaufman Buy +31,250 $0.480 $15,000 Participation in share purchase plan
08/12/16 Paul Rennie Transfer 10,901,075 $0.440 $4,796,473 Off-market transfer
08/12/16 Paul Rennie Transfer 10,901,075 $0.440 $4,796,473 Off-market transfer
09/09/16 John Gaffney Buy +40,000 $0.500 $20,000 On-market trade
10/03/16 Paul Rennie Buy +333,333 $0.300 $100,000 On-market trade
09/12/15 John Gaffney Buy +32,000 $0.310 $9,920 On-market trade
Show All

Director Interests

The current holdings of PAR directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Matthew Fry 04/03/2024 N/A 1,069,830 1,302,372 N/A
Paul Rennie 30/11/2023 8,500,548 12,478,257 349,500 N/A
Donna Skerrett 25/08/2023 1,094,284 N/A N/A N/A
Amos Meltzer 09/12/2020 0 N/A N/A N/A

Shareholder Info

Top 20 Shareholders
About the Data

Data supplied by Morningstar and accurate on Aug 12, 2023.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
Hsbc Custody Nominees Australia Limited 19,967,193 7.09%
Citicorp Nominees Pty Limited 15,408,992 5.47%
Kzee Pty Ltd <Kzee Superannuation Fund A/C> 10,914,902 3.87%
Mr Paul John Rennie 8,500,548 3.02%
J P Morgan Nominees Australia Pty Limited 7,907,224 2.81%
Netwealth Investments Limited <Wrap Services A/C> 7,199,417 2.56%
Bnp Paribas Noms Pty Ltd <Drp> 6,307,738 2.24%
Bnp Paribas Nominees Pty Ltd <Ib Au Noms Retailclient Drp> 5,724,948 2.03%
Wacc Pty Ltd <Progessive Global Fund A/C> 3,959,480 1.41%
Nancy Edith Wilson Ghosh <Ghosh Family A/C> 3,475,835 1.23%
Mr Evan Philip Clucas & Ms Leanne Jane Weston <Kuranga Nursery Super A/C> 3,207,913 1.14%
Bnp Paribas Nominees Pty Ltd Hub24 Custodial Serv Ltd <Drp A/C> 2,616,142 0.93%
Mr Brett Langan 2,303,432 0.82%
V Redford Pty Ltd <Redford S/F A/C> 2,228,500 0.79%
Hsbc Custody Nominees (Australia) Limited A/C 2 1,666,793 0.59%
Australian Executor Trustees Limited <No 1 Account> 1,603,641 0.57%
Ubs Nominees Pty Ltd 1,539,064 0.55%
39Kp Pty Ltd <Ross Family A/C> 1,468,994 0.52%
Ms Lenna Yu Ling Tye 1,441,631 0.51%
Flinders Medical Centre Foundation 1,420,000 0.50%

Shareholder Distribution

As reported in the most recent Annual Report.

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001+ Total
No. of Shareholders 4,641 6,737 2,644 23 27 14,072

Substantial Shareholders

A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.

Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.

Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.

Name Last Notice Total Shares Shares Held (%)
Allianz SE and the entities 12/08/2023 20,215,330 7.09
Paul Rennie and related companies 30/11/2023 20,678,805 5.88

Shareholders Buying

12 month transaction history compiled from ASX announcements.

Date Name Bought Previous % New %
30-11-23 Paul Rennie and related companies 287,571 7.15 5.88

Shareholders Selling

12 month transaction history compiled from ASX announcements.

No sell transactions reported by Substantial Shareholders in the past 12 months.

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
2023 $0.990 30 June
2022 $0.965 30 June
2021 $2.10 30 June
2020 $3.15 30 June
2019 $1.40 28 June
2018 $0.650 29 June
2017 $0.290 28 June
2016 $0.350 28 June
PAR Historical Price Data (CSV)
Up to 20 years of EOD share price history

Important note:

All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)

Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.